Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation clinical trials

Explore recruiting locally advanced or metastatic solid tumors harboring a tp53 y220c mutation clinical trials.

Recruiting locally advanced or metastatic solid tumors harboring a tp53 y220c mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE).

Italy, Germany, France, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation trials by city

Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Toronto Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Vancouver Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Montreal Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Calgary Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Edmonton Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Ottawa Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Winnipeg Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Quebec City Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Hamilton Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Kitchener Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in London Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Halifax Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in New York Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Los Angeles Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Chicago Locally Advanced Or Metastatic Solid Tumors Harboring A Tp53 Y220c Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease